2017 CPhI America ----- Product List

Sinoway Industrial Co.,Ltd

timg (1)(001).jpg2017 CPhI America - Product List1(002).jpg


Our Main Service

Custom Developing / Custom Manufacturing for APIs/ key intermediates and Finish Dosage form.

Import & Export / Technology Transfer for Finish Dosage Form.


ⅡOur Hot Items

"Me-too" new drugs developmentAPI advanced intermediates(Avoid current patent) ----Key intermediates for Sartan series,tatin series,Liptin series,Dipine Series,Tinib series etc.

ii Polypeptide derivatives---Glatiramer,Liraglutide for R&D etc.                             

iii Prostaglandin Derivatives---Cloprostenol Key intermediates etc.

iv Multi-step synthesis skills including chiral compound( more than 15 steps ) and Scale-up in KGand Process Optimization.

PEG Chemistry: PEGylation drugs(4-Arm-PEG-Gyl-Irinotecan and PEG-Naloxone),PEG conjugates and proteins for long term controlled released drugs.

vi Drug delivery system:Block copolymers and "proof-of-concept" for uses in DDS;(For example: Lipids)


Remark:Products covered by valid patents in any country are not offered for sale tothese countries.Products currently under patent protectioncould be available only for R&D purposes if this allowed by local laws.

Sample for R&D use are available as permitted under 35 U.S.C.271(e)(1).


1.jpg2.jpg


Remark:Products covered by valid patents in any country are not offered for sale tothese countries.Products currently under patent protectioncould be available only for R&D purposes if this allowed by local laws.

Sample for R&D use are available as permitted under 35 U.S.C.271(e)(1).

Importing/Technology Transfer for Finish Dosage Form


3.jpg


Remark: Products covered by valid patents in any country are not offered for sale tothese countries.Products currently under patent protectioncould be available only for R&D purposes if this allowed by local laws.

Sample for R&D use are available as permittedunder 35 U.S.C.271(e)(1).


Prostaglandin Derivatives

Product Name

CAS No.

Specification

Prostaglandin series key Intermediates

32233-40-2;

70764-05-7;

39746-00-4;

31752-99-5 etc.

99% up by HPLC

Travoprost  Intermediates

54142-64-2;

208111-98-2 etc.

99% up by HPLC

Bimatoprost Intermediates

41162-19-0;

41639-74-1 etc.

99% up by HPLC

Latanoprost Intermediates

352276-28-9

41639-83-2 etc

99% up by HPLC

Cloprostenol Intermediates

54324-79-7

54713-44-9 etc

99% up by HPLC

Dinoprostone Intermediates

31753-00-1

40834-86-4 etc

98% up by HPLC

Lubiprostone Intermediates

118583-35-0

50889-46-8 etc.

98% up by HPLC


Remark:Products covered by valid patents in any country are not offered for sale tothese countries.Products currently under patent protectioncould be available only for R&D purposes if this allowed by local laws.

Sample for R&D use are available as permitted under 35 U.S.C.271(e)(1).


Pharmaceutical Peptides

Product Name

CAS No.

Specification

Leuprorelin Acetate

74381-53-6

USP34/EP6

Liraglutide Acetate

204656-20-2

99% up by HPLC,S. Impurity<0.1% for R&D

Glatiramer Acetate

147245-92-9

98% up for R&D

Bivalirudin Acetate

128270-60-0

98% up by HPLC

Deslorelin Acetate

57773-65-6

98% up by HPLC

Eptifibatide Acetate

148031-34-9

98% up by HPLC

Exenatide Acetate

141732-76-5

98% up by HPLC

Gonadorelin Acetate

34973-08-5

98% up by HPLC

Goserelin Acetate

145781-92-6

USP /EP

Octreotide Acetate

83150-76-9

USP/EP

Oxytocin Acetate

50-56-6

98% up by HPLC

Somatostatin Acetate

38916-34-6

98% up by HPLC

Teriparatide Acetate

52232-67-4

98% up by HPLC

Triptorelin Acetate

57773-63-4

98% up by HPLC


Remark:Products covered by valid patents in any country are not offered for sale tothese countries.Products currently under patent protectioncould be available only for R&D purposes if this allowed by local laws.

Sample for R&D use are available as permitted under 35 U.S.C.271(e)(1).


Cosmetic Peptides

Product Name

CAS No.

Specification

Copper peptide (GHK)2-CU

49557-75-7

98% up by HPLC

Palmitoyl Oligopeptide(Pal-GHK)

147732-56-7

95% up by HPLC

PalmitoylTetrapeptide-3 (Pal-GQPR )

N/A

95% up by HPLC

Matrixyl 3000

(Pal-GHK:Pal-GQPR=2:1)

N/A

95% up by HPLC

Matrixyl

(Palmitoyl Pentapeptide-4)

214047-00-4

95% up by HPLC

Argireline

(Acetyl Hexapeptide-3)

616204-22-9

98% up by HPLC

SNAP-8 (Acetyl Octapeptide-8)

868844-74-0

95% up by HPLC

Eyeseryl (Acetyl tetrapeptide-5)

820959-17-9

95% up by HPLC

Lipopeptide (Pal-VGVAPG)

171263-26-6

95% up by HPLC

Nonapeptide-1

N/A

95% up by HPLC

Syn-Ake

823202-99-9

95% up by HPLC


Remark:Products covered by valid patents in any country are not offered for sale tothese countries.Products currently under patent protectioncould be available only for R&D purposes if this allowed by local laws.

Sample for R&D use are available as permitted under 35 U.S.C.271(e)(1).


Cosmetic raw materials/Food additives/Exicipients

Alpha/Beta Arbutin                99.5%

Azelaic acid                    99.5% up by HPLC

Beta-Carotene               10% CWS,20%TAB,30% OIL

Citicoline98% up by HPLC

Coenzyme Q10                  EP8/USP38

Fish Collagen                   97%

L-Carnosine                   99%

L-Cysteine Base                 AJI92

L-Glutathione reduced           USP37 / EP7

Natural Creosote                JP16

Phosphatidyl Serine                20% / 50% by HPLC

S-Acetyl-L-Glutathione           98% up

Sodium Hyaluronate 95% up /food grade

S-Adenosyl-L-methionine DisulfateTosylate       USP36


Remark:Products covered by valid patents in any country are not offered for sale tothese countries.Products currently under patent protectioncould be available only for R&D purposes if this allowed by local laws.

Sample for R&D use are available as permitted under 35 U.S.C.271(e)(1).

Herbal Extract


Aloe Vera Extract Aloin 20%,90% by HPLC

Bilberry ExtractAnthocyanins 25% by UV

Giant Knotweed Extract Resveratrol 50%,98%,99%

Ginkgo Bioloba Extract CP, EP

Green Tea Extract Polyphenols 95%-98% by UV

Griffonia Seed Extract  5-HTP 98%,99% by HPLC

Lycopene  5%, 10% 20%

Marigold Extract  Lutein 5%-90% by HPLC

Olive Leaf Extract Oleuropein(water soluble)10~40% Hydroxytyrosol 5%-10% by HPLC

Stevia Extract  RA60%,RA97% up by HPLC

Soybean ExtractIsoflavones 40% by HPLC

Saw Palmetto Extract Fatty Acids 25%-45% by G.C.


Remark:Products covered by valid patents in any country are not offered for sale tothese countries.Products currently under patent protectioncould be available only for R&D purposes if this allowed by local laws.

Sample for R&D use are available as permitted under 35 U.S.C.271(e)(1).


Pharmaceutical Intermediates

Product Name

CAS No.

Specification

Rosuvastatin calcium intermediates

147118-40-9;

147118-35-2 etc.

99% up by HPLC

S. Impurity<0.1%

Pitavastatin calcium intermediates

147511-70-4;

147489-06-3 etc.

99.5%up by HPLC

S. Impurity<0.1%

Sorafenib Intermediates

284462-37-9 etc.

99%up by HPLC

Febuxostat intermediates

160844-75-7 etc.

99%up by HPLC

Entecavir intermediate

1354715-15-3etc

99% up by HPLC

Solifenacin succinate intermediates

118864-75-8 etc.

99%up by HPLC

Rivaroxabanintermediates

446292-07-5 etc.

99%up by HPLC

Vildagliptin intermediate

702-82-9 etc.

99%up by HPLC

1.3-Dichloro Acetone

534-07-6

99%up by HPLC

P-Hydroxybenzyl alcohol

623-05-2

99%up by HPLC


Remark:Products covered by valid patents in any country are not offered for sale tothese countries.Products currently under patent protectioncould be available only for R&D purposes if this allowed by local laws.

Sample for R&D use are available as permitted under 35 U.S.C.271(e)(1).


APIs

Product Name

Quality

Developing Status

Etoposide

USP current

FDA approval

Ifosfamide

USP current

FDA approval

Letrazole

USP current

FDA approval

Irinotecan HCL

USP current

FDA approval

Oxaliplatin

USP current

FDA approval

Dexmedetomidine HCL

USP current

FDA approval

Cisatracurium   besylate

USP current

FDA application

Capecitabine

USP/EP

FDA approval

Lenalidomide

98.0%~102.0%

S.impurity≤0.10%

DMF, FDA application,

Ticagrelor

99%up by HPLC

S.impurity≤0.10%

DMF, FDA application

Pregabalin

99%up by HPLC

GMP, DMF

Ibandronate Sodium hydrate

98.5%~101.5%

S.impurity≤0.10%

GMP, DMF


Remark:Products covered by valid patents in any country are not offered for sale tothese countries.Products currently under patent protectioncould be available only for R&D purposes if this allowed by local laws.

Sample for R&D use are available as permitted under 35 U.S.C.271(e)(1).


APIs

Product Name

Quality

Developing Status

Ezetimibe

99%up by HPLC

GMP,DMF

Nifuratel

99.9%up by HPLC

GMP,DMF preparation

Cinacalcet Hcl

99.9%up by HPLC

GMP,DMF

Azilsartan(Medoxomil)

99%up by HPLC

GMP application,DMF,

Esomeprazole Magnesium dihydrate

99%up by HPLC

GMP application;DMF;

Dabigatran Etexilate Mesylate

99%up by HPLC

GMP application, DMF

Dasatinib hydrate

99%up by HPLC

DMF, GMP application

Erlotinib hydrochloride

99%up by HPLC

DMF, GMP application

Bortezomib

99%up by HPLC

DMF preparation,

Canagliflozin hemihydrate

Amorphous form

98.0%~102.0%

Under PV, DMF,


Remark:Products covered by valid patents in any country are not offered for sale tothese countries.Products currently under patent protectioncould be available only for R&D purposes if this allowed by local laws.

Sample for R&D use are available as permitted under 35 U.S.C.271(e)(1)


Finish Dosage Form

Product Name

Strength

RA Status

Oxaliplatin Injection

50mg/10ml; 100mg/20ml

US FDA

Fondaparinux Injection

0.5ml:2.5mg; 0.4ml:5mg; 0.6ml:7.5mg;   0.8ml:10mg

Pass US FDA Preapproval Inspection

Gabapentin Capsules

0.1g; 0.3g; 0.4g;0.6g;0.8g

Pass US FDA Preapproval Inspection

Letrozole Tablets

2.5mg

US FDA, EU GMP, Japanese PMDA

Doxycycline HCL capsule

100mg

US FDA

Montelukast Sodium Chewable Tablets

4mg;5mg;10mg

US FDA

Capecitabine Tablets

150mg; 500mg

Dossiers will be submitted in 2017.09

Tegafur, Gimeracil, Oteracil Potassium Capsules

1.Tegafur: 20mg, Gimeracil: 5.8mg, Oteracil potassium: 19.6mg;

2.Tegafur: 25mg, Gimeracil: 7.25mg,   Oteracil potassium: 24.5mg

Dossiers have been submitted to US FDA

Pregabalin capsule

25mg;50mg;75mg;100mg;150mg;200mg;225mg;300mg

Dossiers will be submitted in 2017.09

Acarbose tablets

50mg;100mg

EU GMP

Clindamycin HCL  capsules

75mg;150mg;300mg

EU GMP

Iron Sucrose Injection

100mg

Passed GMP audits by many countries

Cinacalcet HCL tablet

25mg;75mg

Passed GMP audits by many countries

Ibandronate Sodium Injection

1ml/ampoule

Passed GMP audits by many countries


Remark:Products covered by valid patents in any country are not offered for sale tothese countries.Products currently under patent protectioncould be available only for R&D purposes if this allowed by local laws.

Sample for R&D use are available as permitted under 35 U.S.C.271(e)(1).